WC11 Podcast – with Dr. Sandra Coecke, the recipient of the Björn Ekwall Memorial Award for the year 2020
Dr. Sandra Coecke, the recipient of the Björn Ekwall Memorial Award for the year 2020, gave recently an interview for WC11 podcast…
The OECD gives the green light to the fish cell line assay!
The OECD gives the green light to the fish cell line assay. The new OECD guideline 249 allows companies to use fish cell line testing for product development and as part of the dossiers for chemical approval.
May ESTIV-ASCCT Webinar: New Approach Methods in genotoxicity and mechanistic toxicity testing for the animal-free safety assessment of novel pharmaceuticals and chemicals
Every year, large numbers of new compounds are being developed for a wide range of purposes…..
The new Biomedical research report from ECVAM: Tackling neurodegenerative diseases with more human relevant research
To promote more human relevant research, the JRC’s EU Reference Laboratory for alternatives to animal testing (EURL ECVAM) led a study to review advanced non-animal models used in the field of neurodegenerative diseases, specifically for Parkinson’s and Alzheimer’s.
ESTIV Corporate member’s event: EPISKIN ACADEMY Webinar
The second EPISKIN webinar is focusing on the theme eye irritation and Integrated Approaches to Testing and Assessment (IATA) for Serious Eye Damage and Eye Irritation for regulatory toxicology…
Webinar + Guidance on gaining acceptance in next generation PBK modelling approaches for regulatory approaches – May 10, 2021
If you are from the community of PBK model developers, or the proponent of a model in a regulatory submission, or a regulator who needs to assess the applicability of the models in chemical evaluations, this webinar is for you!
The report of the Commission’s Second Annual Forum on Endocrine Disruptors has been published
The objective of the Second Annual Forum held on December 17-18, 2020 was to present the actions on endocrine disruptors
Non-animal Methods in Science and Regulation
The annual EURL ECVAM status report describes research, development and validation activities, as well as initiatives that promote the regulatory use and international adoption of non-animal methods and approaches and their dissemination in the regulatory and research arenas.